Search results
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters via AOL· 2 days agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...
Is Ozempic an Obesity Drug, or an Everything Drug?
The Atlantic· 4 days agoPeople who take Ozempic or other weekly shots belonging to a class known as GLP-1 agonists, after the gut hormone they mimic, can lose a fifth or more of...
Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
Barrons.com· 3 days agoOzempic, the brand name under which the same medicine is sold as a Type 2 diabetes treatment, has a...
Making the case for Wegovy coverage: Drug keeps weight off for 4 years, aids heart health
BenefitsPRO· 4 days agoDrugmaker Novo Nordisk has released two new trial results that could strengthen the case for...
Jim Cramer says Eli Lilly isn't a ‘one trick pony' after FDA advisers endorse its Alzheimer's drug
NBC San Diego· 4 days agoContinually confident about Eli Lilly because of the enormous success of its weight loss and diabetes drugs, CNBC's Jim Cramer said the company's new Alzheimer's treatment ...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 4 days agoEli Lilly became the most valuable health-care company in the world on the back of its blockbuster ...
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster | The Motley Fool
The Motley Fool· 5 hours agoEli Lilly's (LLY -0.55%) name has become somewhat synonymous with its work in diabetes and obesity...
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
CNBC· 4 days agoCNBC's Jim Cramer on Tuesday explained why he continues to be bullish about pharmaceutical giant Eli...
3 Stocks to Sell as Ozempic Surges in Popularity
InvestorPlace· 1 day agoNovo Nordisk’s (NYSE:NVO) Ozempic diabetes treatment, marketed as a weight loss treatment under the Wegovy brand name, has become the latest...
Michigan’s largest insurer to drop weight-loss drug coverage - Indianapolis Business Journal
Indianapolis Business Journal· 3 days agoWeight-loss drugs from Novo Nordisk A/S and Indianapolis-based Eli Lilly and Co. will lose coverage...